Molecular characterization of PRM-associated endometrial changes, PAEC, following mifepristone treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Molecular characterization of PRM-associated endometrial changes, PAEC, following mifepristone treatment

Published:2018-10 Issue:4 Volume:98 Page:317-322
ISSN:0010-7824
Container-title:Contraception
language:en
Short-container-title:Contraception

Author:

Berger C.,Boggavarapu N.,Norlin E.,Queckbörner S.,Hörnaeus K.,Falk A.,Engman M.,Ramström M.,Lalitkumar P.G.L.,Gemzell-Danielsson K.

Funder

Swedish Research Council

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Reproductive Medicine

Reference29 articles.

1. The immninent dawn of SPRMs in obstetrics and gynecology;Chabbert-Buffet;Mol Cell Endocrinol,2012

2. Weekly contraception with mifepristone;Pei;Contraception,2007

3. Effects of low doses of mifepristone on human embryo implantation process in a three-dimensional human endometrial in vitro co-culture system;Boggavarapu;Contraception,2016

4. Inhibition of ovulation by low-dose mifepristone (RU 486);Ledger;Hum Reprod,1992

5. Daily low-dose mifepristone has contraceptive potential by suppressing ovulation and menstruation: a double-blind randomized control trial of 2 and 5 mg per day for 120 days;Brown;J Clin Endocrinol Metab,2002

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Mifepristone vs Placebo for Treatment of Adenomyosis With Pain Symptoms;JAMA Network Open;2023-06-12

2. Clinical Update on Uses for Mifepristone in Obstetrics and Gynecology;Obstetrical & Gynecological Survey;2022-10

3. Investigation of the 12-month efficacy and safety of low-dose mifepristone in the treatment of painful adenomyosis;Reproductive and Developmental Medicine;2022-09

4. The Role of Glucocorticoid Receptor in the Pathophysiology of Pituitary Corticotroph Adenomas;International Journal of Molecular Sciences;2022-06-09

5. Pharmacological inhibition of 17β-hydroxysteroid dehydrogenase impairs human endometrial cancer growth in an orthotopic xenograft mouse model;Cancer Letters;2021-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3